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The K-Cl cotransporter KCC2 plays a crucial role in the functional development of GABAA-mediated responses rendering GABA
hyperpolarizing in adult neurons. We have previously shown that BDNF upregulates KCC2 in immature neurons through the
transcription factor Egr4. The eﬀect of BDNF on Egr4 and KCC2 was shown to be dependent on the activation of ERK1/2. Here
we demonstrate that the trophic factor neurturin can also trigger Egr4 expression and upregulate KCC2 in an ERK1/2-dependent
manner. These results show that Egr4 is an important component in the mechanism for trophic factor-mediated upregulation of
KCC2 in immature neurons involving the activation of speciﬁc intracellular pathways common to BDNF and Neurturin.
1.Introduction
The maturation of GABAA mediated neurotransmission
encompasses long-term qualitative changes in postsynap-
tic responses. Particularly important is the developmental
shift from depolarizing to hyperpolarizing GABAA-evoked
responses. This transition is attributed to the increase in
expression of the K-Cl cotransporter KCC2. The functional
expression of this cotransporter keeps the intraneuronal
chloride concentration below that predicted from passive
distribution rendering the GABAA reversal potential more
negative than the resting membrane potential [1].
We have shown previously that BDNF-mediated TrkB
activation can regulate the expression of KCC2 diﬀerentially
in adult and in early postnatal neurons [2–4]. Activation of
TrkB by BDNF triggers two major intracellular cascades [5–
8], namely, the Shc and the PLCγ pathways. (i) The Shc
pathway includes the activation of a number of adaptor
proteins such as Shc, SOS, and Grb2 that results in the
GTP-loading of Ras that subsequently leads to the activation
of the MAP kinase cascade. This comprises the sequential
phosphorylation of Raf, Mek, and Erk. The phosphorylated
Erk is then translocated to the nucleus where it can activate
and induce the expression of transcription factors. (ii) In
the PLCγ pathway, direct activation of PLCγ by TrkB leads
to the breakdown of PIP2 into DAG and IP3.A c t i v a t i o n
of PKC by DAG promotes the release of intracellular Ca2+
and the activation of Ca2+-dependent proteins. Interestingly,
although BDNF induces under normal physiological con-
ditions downregulation of KCC2 in adult neurons, it can
induce KCC2 up-regulation if TrkB activation speciﬁcally
evokes signaling through the Shc pathway only [2, 4]. Also in
immature neurons BDNF can induce KCC2 up-regulation in
an MAPK-dependent manner acting though the transcrip-
tion factor Egr4 [3] suggesting that BDNF/TrkB-mediated2 Neural Plasticity
upregulation of KCC2 use intracellular pathways down-
stream of Shc.
Other neurotrophic factors, can also trigger Shc/MAPK
signaling. Neurturin belongs to the GDNF family of neu-
rotrophic factors and it speciﬁcally binds to the GPI-
anchored receptor GRFα2. The ligand binding triggers
association of GFRα2 with transmembrane tyrosine-kinase
receptor RET that in turn can activate signaling pathways
including the Shc/MAPK intercellular cascades [9].
In the present report, we study the eﬀect of Neurturin on
the regulation of KCC2 at the transcriptional level. We found
that Neurturin can trigger the expression of Egr4. Accord-
ingly,NeurturininducestheactivationoftheKCC2proximal
promoterregionthatresultsinasigniﬁcantincreaseinKCC2
protein expression in immature neurons. Most importantly,
this requires MEK-dependent ERK phosphorylation. We
also show that Neurturin can evoke up-regulation of KCC2
in vivo after a single intrahippocampal application. Taking
into account that BDNF, acting through similar intracellular
signaling cascades, is able to up-regulate KCC2 in immature
neurons,weproposeageneralmechanismfortrophicfactor-
mediatedKCC2generegulationinimmatureneurons,where
Egr4downstreamoftheMAPK/ERKsignaling pathwayplays
a crucial role.
2. Methods
2.1. Dissociated Cultures. All animal experiments were
approved by the local ethics committee for animal research
at the University of Helsinki. Standard dissociated hip-
pocampal cultures were prepared from embryonic day 17
(E17) mice as described in the original protocol [10],
with slight modiﬁcations. Brieﬂy, a pregnant mouse was
anaesthetized in a CO2 chamber and sacriﬁced by cervical
dislocation, embryos were removed, and hippocampi were
dissected. Cells were dissociated by enzymatic treatment
(0.25% trypsin for 15min at 37◦C) and plated on poly-DL-
ornithine-coated coverslips (50000cells/cm2) in neurobasal
medium containing B27 supplement (Gibco, Life Technolo-
gies). Before plating, the medium was preincubated on
astroglial culture for 24 hours. Neuronal cultures were fed
once a week by changing half of the medium. Astroglial
cultures were prepared according to Banker and Goslin,
1998, and maintained in DMEM supplemented with 10% of
foetal calf serum, penicillin100units/mL, and streptomycin
100μg/mL.
2.2. Organotypic Cultures. Hippocampal organotypic cul-
tures were prepared according to the method of Stoppini
[11]. Transverse slices (thickness 350μm) were cut from
the hippocampi from P8 mice using a McIlwain tissue
chopper. They were immediately placed on sterile Millicell-
CMmembranes(Millipore)in6-wellculturetrayswith1mL
of plating medium. The plating medium was neurobasal
medium containing B27 supplement (Gibco, Life Technolo-
gies), penicillin 100units/mL and streptomycin 100μg/mL.
Onedayafterplatingthemediumwaschangedtothegrowth
medium Neurobasal/B27 without antibiotics. The cultures
were grown at 37◦C under 5% CO2 in air, and the medium
was changed twice a week.
2.3. Application of Growth Factors. Treatments of organ-
otypic cultures were performed from div (day in vitro)2
until div5. Dissociated cultures were treated with Neurturin
during div1–div4, div8–div11, and div15–18. Neurturin
(PeproTech Inc.) was added from the frozen stock once on
the ﬁrst day of the treatment period. The ﬁnal concentration
of Neurturin is indicated in Section 3.
2.4. Western Blotting. Neuronal cultures were rinsed in PBS,
scraped into ice-cold lysis buﬀer (NaCl 150mM; TritonX-
100 1%; Doc 0.5%; SDS 0.1%; TrisHCl 50mM pH 8.0)
and homogenized. Hippocampal slices were homogenized
directly with lysis buﬀer. Protein concentrations were deter-
mined using DC Protein Assay kit (Bio-Rad). Samples
were separated using 7.5% SDS-PAGE and transferred
onto Hybond ECL nitrocellulose membrane (Amersham,
Pharmacia Biotech). Blots were probed with anti-KCC2
rabbit polyclonal antibody [12] at 1:5000 dilution and anti-
β-tubulin rabbit polyclonal antibody (Covance, PRB-435P,
1:3000), developed with ECL-plus (Amersham, Pharmacia
Biotech), and visualized with luminescent image analyzer
LAS-3000 (Fujiﬁlm). Optical densities of the bands were
analyzed with AIDA imaging software (Raytest).
2.5. Semi-Quantitative RT-PCR. Neuronal dissociated cul-
tures treated with growth factors were used for total RNA
isolation and reverse transcription reaction. Total RNA was
isolated using RNeasy Mini Kit (Qiagen) according to man-
ufacturer’s instructions. Isolated RNA samples were reverse
transcribed using random hexamer primers and Superscript
II reverse transcriptase (Life Technologies). The samples
after reverse transcription were diluted 1/10, 1/20, 1/50,
1/100, and ampliﬁed for 30–34 cycles using DyNAzyme EXT
polymerase (Finnzymes) to keep the product ampliﬁcation
in the exponential range for every primer pair (see Table 1).
The PCR conditions for all primer pairs were the same:
2min of the initial denaturation at 95◦C followed by 30–
34 cycles with 95◦C for 30sec, 55◦Cf o r3 0 s e c ,a n d7 2 ◦C
for 1min. Products were analyzed on 1.5% agarose gel
and visualized with luminescent image analyzer LAS-3000
(Fujiﬁlm). Optical densities of the bands were analyzed with
AIDA imaging software (Raytest).
2.6. Quantitative RT-PCR Analysis. Total RNA was isolated
with the RNeasy Micro (Qiagen) kit. Typically, about 1μg
of total RNA was reverse transcribed using the SuperScript
III Reverse Transcriptase (Life Technologies) and random
primers (at 37◦C) according to the manufacturer’s protocol.
The cDNA samples were ampliﬁed using the SYBR Green
PCR Master Mix (Applied Biosystems) and detected via the
ABIPrism7000SequenceDetectionSystem(AppliedBiosys-
tems). Primers for Egr4 and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) quantiﬁcation were designed with
the Express v2.0 software (Applied Biosystems) and con-
tained, when possible, intronic sequence in between (see
Table 2).Neural Plasticity 3
Table 1
Product Forward Reverse
RET 5 -AGGACCACACATCACTTTGAG-3  5 -ATGAAAGGGTACTGACCATGG-3 
GFRα25  -TATTGGAGCATCCATCTGGG-3  5 -AGCAGTTGGGCTTCTCCTTG-3 
GAPDH 5 -GCAAAGTGGAGATTGTTGCCAT-3  5 -CCTTGACTGTGCCGTTGAATTT-3 
Table 2
Product Forward Reverse
Egr4 5 -TCTCTCCAAGCCCACCGAAG-3  5 -AACCGCCTGGATGAAGAAGC-3 
GAPDH 5 -GCAAAGTGGAGATTGTTGCCAT-3  5 -CCTTGACTGTGCCGTTGAATTT-3 
2.7. Transfection and Luciferase Assay. The neurons were
transfected with the luciferase reporter construct using
Lipofectamine 2000 (Life Technologies) according to the
manufacturer’s protocol at div5. To avoid cytotoxicity, we
used relatively low amounts of the luciferase construct
(0.5μg per 1-cm-diameter well). Two days after transfection
the neurons were brieﬂy washed with phosphate-buﬀered
saline (PBS) and lysed in Passive Lysis Buﬀer (Promega).
Renilla and Fireﬂy luciferase activities were measured with
a Dual-Luciferase Reporter Assay System according to the
manufacturer’s protocol.
2.8. In Vivo Injections of Neurturin. Neurturin (1μg) was
injected in hippocampus of P5-P6 rats. Animals were
hypothermicallyanesthetizedandheadswereﬁxedinasurgi-
cal mask to maintain the skull stable. A midline incision was
made on the head, and the hole was drilled in the skull. The
stereotactic coordinates for injection were anteroposterior-
1.8mm (relative to the bregma), mediolateral 2mm (relative
to the bregma), dorsoventral-2mm from the corticalsurface.
Neurturin was dissolved in 4μL of saline solution (123mM
NaCl, 5mM KCl, 1,25mM NaH2PO4,2m MM g S O 4,1 0m M
glucose, 2 mM CaCl2, 10mM HEPES, and pH 7.2) and
injected in right-side hippocampus at ∼1μL/min. Similarly
left-side hippocampus was injected with 4μL of pure saline
solution. After injection, the needle was left in the tissue for
2minutes. The incision was sutured and the rat was allowed
to fully recover before being placed back with littermates.
2.9. Image Analysis. For each injected brain a series of
coronal hippocampal sections (see immunohistochemistry)
was made at P8-P9, three days after injection. The sections
in the series were numbered in succession starting from
most frontal part of hippocampus. Each section contained
Neurturin-injected side (right) as well as control side (left).
KCC2 levels were analyzed by immunostaining in sections
number 45, 90, 132, 177, 222, and 273. The section thickness
was 7μM which gives a sample interval of approximately
315μm. In each brain analyzed, the injection site (deﬁned
by a scar) was found between section number 60 and section
number 90 and located in right and left hemisphere in CA1
area of hippocampus.
Confocal images of immunostained tissue were made.
For each image nine consecutive optical slices (0.8μm) were
made and merged for quantiﬁcation of KCC2 signal inten-
sity. The region of interest was manually highlighted and
total intensity of immunostaining in the region was divided
by its area. KCC2 intensity in Neurturin-injected hemisphere
was normalized to the KCC2 intensity in corresponding area
of the same section control hemisphere.
2.10. Immunohistochemistry. Rats were deeply anaesthetized
with pentobarbital and perfused with 4% PFA in PBS. Brains
were removed and stored overnight in 4% PFA in PBS at
4◦C .T i s s u e sw e r ep a r a ﬃn embedded and cut into 7-μm-
thick sagittal (in situ) or coronal (in vivo injections) sections.
Deparaﬃnized sections were washed with 1% SDS in TBST
(0.1% Tween in TBS), treated with 100μg/mL saponin in
TBST for 30min at room temperature, and then treated with
5% bovine serum albumin (BSA) in TBST for two hours
at room temperature. Next, tissues were incubated with
anti-KCC2 rabbit polyclonal antibody [12] diluted at 1:5000
in 2% BSA, 0.2% Triton X-100, TBST overnight at 4◦C.
Species-speciﬁcsecondaryantibodies:donkeyantirabbitCy3
(Jackson Laboratories, 711-166-152), donkey anti-rabbit
Alexa Fluor 488, and goat antiguinea pig Alexa Fluor 488
(Molecular Probes, Invitrogen, catalog number: A-21206, A-
11073, resp.) were used at 1:400 dilution. Sections were
visualized with Leica TCS SP2 AOBS confocal system.
2.11. In SituHybridization. In situhybridization on paraﬃn-
embedded sections was done as described [13]. Sagittal
sections (thickness 7μm) were hybridized using 35S-labelled
antisense and sense (control) cRNA probes: RET-speciﬁc
probe (nucleotides 2595–3191, X67812) and GFRα2 (full
length, AF003825) [14]. No labeling above background was
observed in the sense controls.
2.12. Statistics. The data represents the mean ± SEM.
Statistical analysis was performed using one sample t-test in
GraphPad Prism statistical software. Statistical signiﬁcance
was deﬁned as ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001; n
represents the number of independent experiments.
3. Results
3.1. Neurturin Upregulates KCC2 Expression in Developing
Organotypic and Dissociated Hippocampal Cultures. Our
previous results provided evidence that Egr4 and KCC24 Neural Plasticity
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Figure 1: Regulation of KCC2 expression by Neurturin. (a) Representative Western blot analysis of Neurturin-induced ERK1/2
phosphorylation.Lysatesofdiv5-dissociatedcultureswerecollected5–20minafterNeurturin(50ng/mL)application.Insomecasescultures
were pretreated with MEK inhibitor U0126 (20μM) 30 min before Neurturin application. (b) Egr4 mRNA level in div5–div10 dissociated
cultures 1-2hours after Neurturin (50ng/mL) application as detected by real time PCR (n = 5). Nontreated control value was set to 1.
(∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001). Error bars represent SEM. (c) Representative Western blot analysis and quantiﬁcation of KCC2
expression in organotypic hippocampal slice cultures treated with NTRN (n = 4–8). Organotypic cultures were treated with 10ng/mL and
50ng/mL Neurturin. Data are normalized to the value in nontreated controls (∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001). Error bars represent
SEM. (d) Representative Western blot analysis and quantiﬁcation of KCC2 expression in dissociated hippocampal cultures treated with
Neurturin (50ng/mL) (n = 3–7). Dissociated cultures were treated with Neurturin at div1, div8 and div15 and analyzed 3 days after the
treatment. Data are normalized to the value of non-treated controls of the corresponding age (∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001). Error
bars represent SEM. (e) Representative semiquantitative RT PCR from cDNA of diﬀerent age cultures for RET, GFRα2, and GAPDH (used as
internal standard) and summarized results of 3 similar PCRs. The data show that dissociated hippocampal neurons express detectable levels
of growth factors receptors at all ages tested. Data are normalized to div4 value. Error bars represent SEM.Neural Plasticity 5
expression is regulated through ERK1/2-dependent mech-
anism [3]. This may imply that other means of MAPK
activation might lead to the induction of KCC2 expres-
sion. Thus we analyzed the eﬀect of Neurturin, another
troph-ic factor that also induces MAPK activation [15].
In hippocam-pal primary cultures ERK1/2 phosphorylation
was induced 5minutes after Neurturin (50ng/mL) applica-
tion (Figure 1(a)). The eﬀect was sensitive to MEK blocker
U0126 (20μM). Similarly to our previous results with BDNF
[3], Neurturin induced Egr4 expression: Egr4 mRNA levels
were 1.6 ± 0.2-fold higher than in control one hour after
Neurturin application (Figure 1(b)).
Although acting through a very diﬀerent type of tyrosine
kinase receptor, Neurturin, similarly to BDNF, signiﬁcantly
upregulated KCC2 protein expression at 10 and 50ng/mL
(129 ± 4% and 171 ± 16%; 10 and 50ng/ml resp.
Figure 1(c)). Interestingly, the eﬀect of Neurturin also had a
ten-dency to decline with culture maturation. The strongest
up-regulation of KCC2 was observed in two-weeks-old
cultures (130 ± 7% of control; Figure 1(d)).
The developmental change in the eﬀect of the neurotro-
phic factors could be caused by a diﬀerence in the expression
level of corresponding receptors. Thus we monitored the ex-
pression of Neurturin coreceptors RET and GFRα2 in disso-
ciated cultures at div4, div11, and div18 by semiquantitative
RT-PCR (Figure 1(e)). The PCR results showed that mRNAs
for these receptors were detectable at all ages investigated.
When compared to div4, GFRα2 mRNA was down-regulated
to 32 ± 16% at div25. This change in GFRα2 expression may
have a role in the developmental diﬀerences in the eﬀect of
Neurturin on KCC2 expression.
These data provide evidence that Neurturin, similarly to
BDNF, is able to enhance endogenous KCC2 expression in
vitroduringearlypostnatalperiodinadose-dependentman-
ner. The developmental change in trophic factor-mediated
regulation of KCC2 expression may be a consequence of
corresponding changes in trophic factor receptor expression.
3.2. Neurturin Activation of KCC2 Proximal Promoter Region
is Dependent on MEK Phosphorylation. Using the luciferase
(Luc) reporter construct KCC2(−309/+42) driven by the
proximal promoter region of KCC2 (Figure 2(a))w ep e r -
formed experiments on hippocampal primary cultures aim-
ing to further study Egr4 involvement in the neurotrophic
factor-induced KCC2 up-regulation (for detailed scheme of
construct generation see [16]).
Dissociated neurons were transfected with KCC2
(−309/+42) at div4 and treated with 50ng/mL Neurturin
two days after transfection. Two to four hours after the
trophic factor application, culture lysates were analyzed
for Luc activity (Figure 2(b)). We observed substantial
increase in KCC2 promoter activity in cultures treated
with Neurturin (117 ± 5% of nontreated controls). The
Neurturin-induced increase in KCC2 promoter activity was
abolished by MEK1/2 inhibitor U0126 (20μM).
3.3. Expression Pattern of the Neurturin Receptors GFRα2
and RET in the Early Postnatal Hippocampus. In contrast to
TrkB receptor, in which expression is well characterized in
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Figure 2: Neurturin-induced activation of KCC2 proximal pro-
moter region. (a) Schematic drawing of the luciferase construct
carrying the KCC2 proximal promoter region. The construct
contains the luciferase reporter gene under control of a short
(309bp) upstream proximal part of the KCC2 promoter sequence.
(b) Normalized luciferase activity 2–4 hours after application
of 50ng/mL Neurturin in div7 hippocampal neuronal cultures
transfected with the KCC2 (−309/+42) construct (n = 4; ∗∗P<
0.01). Error bars represent SEM.
early postnatal brain [17], detailed data on Neurturin co-
receptors RET and GFRα2 expression in the hippocampus
are scarce. Two studies addressed the question of GFRα2a n d
RET expression in developing hippocampus by RT PCR and
in situ hybridization [18, 19]. Both studies showed that after
birth GFRα2 mRNA expression reaches maximum at around
P5 and it is downregulated during later development. The
in situ hybridization study [18, 19] also demonstrated that
at P4 a prominent RET and GFRα2 mRNA expression was
localized to CA3 pyramidal layer while GFRα1m R N Aw a s
only weakly abundant there.
We analyzed the temporal and spatial pattern of GFRα2
and RET mRNA expression during early postnatal develop-
ment in our conditions in order to estimate the best optimal
time point to test the eﬀect of Neurturin in vivo. In situ
hybridization of consecutive sagital rat brain sections at E17,
P3, P5, and P9 (Figure 3(a)) showed that RET and GFRα2
signals were relatively low but most prominent at P3 and P5.
RET mRNA expression showed a general dispersed pattern.
Interestingly, GFRα2 mRNA was most prominent in the
pyramidal layer of the CA3 region (white arrowheads).
3.4. Neurturin Increases KCC2 Expression in P5-P8 Mice
Hippocampus In Vivo. We investigated the eﬀect of intrahip-
pocampal Neurturin injections on KCC2 expression. In
accordance with receptor expression data, Neurturin was
injected in hippocampi of P5 rats. In the initial series of
experiments two doses of Neurturin were tested: 100ng and
1μg.ThelowerdoseofNeurturinhadnosigniﬁcanteﬀecton6 Neural Plasticity
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Figure 3: Regulation of KCC2 expression by Neurturin in vivo. (a) RET and GFRα2 mRNA expression was detected by in situ hybridization.
Note the accumulation of RET and GFRα2 at P3 and P5 in the CA3 region of the hippocampus (marked with arrowheads). Scale bar =
500μm. (b) Representative immunoﬂuorescent stainings of KCC2 expression in Neurturin-treated and control hippocampi 3 days after in-
jection.Neurturin(1μg)wasusedforinjectioninright-sidehippocampusofP5ratwhilecontralateralhippocampuswasinjectedwithsaline
solution.(c)SummaryresultsofKCC2immunostainingintensityfordiﬀerentlayersofCA1andCA3inNeurturin-injectedhemisphere(n =
16–21). KCC2 intensity was measured in 6 sections at various distances from injection site. The eﬀect of Neurturin injection was uneven
along the dorsal-ventral axis. Quantiﬁcation was made for the following layers: CA3 is whole area of CA3; pCA3 and pCA1 are pyramidal
layers of CA3 and CA1, respectively; SO is stratum oriens; SR is stratum radiatum and LM is stratum lacunosum-moleculare. In each section
andeachlayerKCC2intensityinNeurturin-injectedhemispherewasnormalizedtothecorrespondingvalueincontrolhemisphere.Thenfor
each layer the maximum, the minimum, and the average values of KCC2 intensity along the dorsal-ventral axis were calculated (∗∗P<0.01,
∗∗∗P<0.001). Error bars represent SEM. Scale bar = 300μm.
KCC2 expression (data not shown). All further experiments
were performed using 1μg of Neurturin.
Single injection of Neurturin produced a signiﬁcant
increase in KCC2 expression (Figures 3(b) and 3(c)). KCC2
levels were analyzed three days after the Neurturin injection
by immunostaining. Representative KCC2 immunostaining
of the areas with maximal Neurturin eﬀect are presented
in Figure 3(b). Summarized data for three independent
experiments are shown in Figure 3(c). KCC2 up-regulation
after Neurturin injection was signiﬁcant in all hippocampal
areas analyzed. The maximal eﬀect of Neurturin (150% of
control) was observed in CA3 area.
Taken together, the in vivo experiments indicate that
within three days after a single application of Neurturin in
developing hippocampus, there is a substantial increase in
the level of KCC2 expression.Neural Plasticity 7
4. Discussion
Identiﬁcation of the intracellular cascades involved in KCC2
regulation is crucial for understanding the mechanisms
rendering long-term plastic changes in GABAA mediated
transmission during development and trauma. Both BDNF
and Neurturin can activate similar intracellular cascades
that include Shc/Frs2 which in turn triggers the MAPK and
AKT signaling [5, 15]. The MAPK pathway is known to be
involved in diﬀerentiation and maturation whereas AKT is
implicated in cell growth and survival. The results obtained
in the present study clearly show that it is activation of
the MAPK intracellular pathway that is crucial for both
BDNF—[3] and Neurturin—induced expression of KCC2 in
immature neurons. Suppression of MAPK signaling by the
speciﬁc MEK inhibitor U0126 resulted in a signiﬁcant block
of BDNF-[3, 20] and Neurturin—induced KCC2 promoter
activationaswellasNeurturin-inducedEgr4expression.Our
previously published results showed that in adult neurons
activation of mutant TrkB receptor, in which only Shc/Frs2
docking site was preserved, resulted in KCC2 up-regulation
[2] thus emphasizing the importance of this pathway not
only during development but also under pathophysiological
conditions.
Our previous results demonstrated that early growth
response factor Egr4 induced KCC2 transcription [16]a n d
mediated the BDNF-induced KCC2 up-regulation [3]i n
immature neurons. In the present work we show that similar
to the eﬀect of BDNF, Neurturin signiﬁcantly up-regulates
Egr4. This obviously leads to the question whether Egr4 is
involved in the Neurturin-induced KCC2 up-regulation. The
crucial role of Egr4 in this process is particularly indicated
by the experiment where Neurturin displays a signiﬁcant
activation of the proximal promoter region of KCC2 that
carries the binding site for Egr4. Consistent with the in
vitroresults,in vivo intrahippocampal injection of Neurturin
produced a signiﬁcant up-regulation of KCC2 protein in
neonatal rat hippocampus.
The family of GDNF ligands are potent survival promot-
ing trophic factors that act primarily through the interaction
with GFRα coreceptors and signal through the activation
of the receptor tyrosine kinase RET. Resent results suggest
that, additionally, this family of trophic factors could signal
through alternative signaling pathways [21]. The temporal
and spatial eﬀect of Neurturin correlated both in vitro and
in vivo with the expression proﬁle of RET and GFRα2,
suggesting that this eﬀect was mediated trough the speciﬁc
activation of these receptors. More detailed analysis of the
eﬀect of Neurturin on KCC2 expression in GFRα2−/− mice
in the future will give a more decisive answer to whether this
eﬀect is mediated trough GFRα2/RET.
In conclusion the present results are in agreement with
a central role of the intracellular MAPK/ERK pathway as
convergent point for diﬀerent parallel extracellular cues.
Activation of the MAPK pathway by these extracellular
signals induces immediate early gene Egr4 expression that
in turn stimulates KCC2 up-regulation. These may lead to
in-creased Cl− extrusion eﬃciency causing the maturation
of GABAA mediated responses. These results suggest that
there may be several extracellular signals able to induce
KCC2 up-regulation in developing neurons. One question
for the future is whether Neurturin and BDNF have syner-
gistic action in vivo to regulate KCC2 during development.
Another important question raised by the present study is
whetherparallelmechanismsregulatingKCC2expressionare
in place also under pathophysiological conditions.
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